Autism Speaks Funds Studies of ASD Biomarkers, Predisposition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Autism Speaks' most recent round of research funding, totaling $13.2 million, includes grants for projects that delve into molecular, genetic, and epigenetic factors that may be involved in autism spectrum disorder.

Alongside its Basic and Clinical research program grant, the non-profit said yesterday that it also has funded projects through the new Translational Postdoctoral Fellowship program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.